top of page
Duncan Hall, CEO, on why we developed OPRA 5
Operational Platform for Risk Analysis (OPRA) is the industry leading platform for risk-based monitoring and risk-based quality management. In this short video from Duncan Hall, CEO of TRI, he takes you through why we developed the new version 5 platform from the ground up, and the features and benefits it brings to anyone running a clinical trial.
To see the full content, please click on the button below.
bottom of page